2 Soaring Stocks Wth More Upside Potential
Although fundamental investing wisdom tells us to “buy low,” it may still be worthwhile to purchase shares of top companies following significant runs. Any point can be considered low — even after massive gains — provided there is plenty of upside left. That brings us to Summit Therapeutics (NASDAQ: SMMT) and Axsome Therapeutics (NASDAQ: AXSM),…